Februar 2009 - IOZK

Genetically engineered Newcastle disease virus for malignant melanoma therapy

2009-02-26/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2009-02-26 / Gene Ther. 2009 Jun;16(6):796-804

Strong synergy of heat and modulated electromagnetic field in tumor cell killing

2009-02-25/in Hyperthermia, International Publications /von 2009-02-25 / Strahlenther Onkol 2009 Feb;185(2):120-6

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

2009-02-19/in Acute Leukemia, International Publications /von 2009-02-19 / Cancer Immunol. Immunother. 2009 Oct;58(10):1669-77

Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses

2009-02-17/in Hypernephroma, International Publications /von 2009-02-17 / Cancer Immunol. Immunother. 2009 Oct;58(10):1587-97

Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice

2009-02-15/in Colorectal Cancer, International Publications /von 2009-02-15 / Int. J. Cancer 2009 Feb;124(4):877-88

Dendritic-cell- and peptide-based vaccination strategies for glioma

2009-02-13/in Glioblastoma, International Publications /von 2009-02-13 / Neurosurg Rev 2009 Jul;32(3):265-73; discussion 273

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

2009-02-10/in International Publications, Newcastle Disease Virus /von 2009-02-10 / Mol. Ther. 2009 Apr;17(4):697-706

FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer

2009-02-08/in International Publications, Prostate Cancer /von 2009-02-08 / Clin. Immunol. 2009 Apr;131(1):1-10

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer

2009-02-05/in Dendritic Cells, International Publications /von 2009-02-05 / Vaccine 2009 May;27(25-26):3401-4

Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses

2009-02-03/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2009-02-03 / Cancer Res. 2009 Feb;69(4):1448-58